This list is an analysis based on recent market events. It's not an investment recommendation.
About
Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, the United States, France, the Middle East, Belgium, Italy, and Finland. It offers ASTar, an antimicrobial susceptibility testing (AST) technology used in the treatment of bloodstream infections and sepsis; and ASTar BC G- Kit which contains two disposables, including a sample preparation cartridge and an AST disc, used with the Frozen insert. The company also develops Podler, a portable blood culture technology. It serves physicians, hospitals, laboratories, healthcare payers, and the medical profession. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.
The current price of QLINEA-BTA.ST is SEK24.90 SEK — it has increased by +0.4% in the past 24 hours. Watch Q-Linea AB stock price performance more closely on the chart.
What is Q-Linea AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Q-Linea AB stocks are traded under the ticker QLINEA-BTA.ST.
What is Q-Linea AB market cap?▼
Today Q-Linea AB has the market capitalization of 471.83M
When is the next Q-Linea AB earnings date?▼
Q-Linea AB is going to release the next earnings report on October 30, 2026.
What is Q-Linea AB revenue for the last year?▼
Q-Linea AB revenue for the last year amounts to 11.1M SEK.
What is Q-Linea AB net income for the last year?▼
QLINEA-BTA.ST net income for the last year is -182.49M SEK.
How many employees does Q-Linea AB have?▼
As of September 06, 2026, the company has 70 employees.
In which sector is Q-Linea AB located?▼
Q-Linea AB operates in the Health & Wellness sector.